Q2 2024 · 13F-HR
BROADWOOD CAPITAL INCholdings as filed
Filed 2024-08-14 · accession 0000919574-24-004545
$1.32B
Reported value
7
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 852312305 | STAA | STAAR SURGICAL CO | $512.7M | 38.8% | 10,768,431 | Common | SOLE |
| 61174X109 | MNST | MONSTER BEVERAGE CORP NEW | $414.4M | 31.3% | 8,295,690 | Common | SOLE |
| 05464C101 | AXON | AXON ENTERPRISE INC | $223.6M | 16.9% | 760,062 | Common | SOLE |
| 464287655 | IWM | ISHARES TR | $114.8M | 8.68% | 566,000 | Common | SOLE |
| 53566P109 | LCTX | LINEAGE CELL THERAPEUTICS IN | $41.6M | 3.14% | 41,666,255 | Common | SOLE |
| 68235C206 | IMDX | ONCOCYTE CORP | $14.5M | 1.10% | 4,929,066 | Common | SOLE |
| 81751A108 | SER | SERINA THERAPEUTICS INC | $816,398 | 0.06% | 85,219 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.